tiprankstipranks
Trending News
More News >
Eupraxia Pharmaceuticals, Inc. (TSE:EPRX)
:EPRX
Canadian Market

Eupraxia Pharmaceuticals (EPRX) Income Statement

Compare
26 Followers

Eupraxia Pharmaceuticals Income Statement

Last quarter (Q1 2025), Eupraxia Pharmaceuticals's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Eupraxia Pharmaceuticals's net income was C$-6.76M. See Eupraxia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -235.25KC$ -209.91KC$ -193.27KC$ -111.53KC$ -116.81K
Operating Expenses
C$ 36.76MC$ 37.92MC$ 23.20MC$ 18.68MC$ 2.25M
Depreciation and Amortization
C$ 235.25KC$ 209.91KC$ 193.27KC$ 111.53KC$ 116.81K
EBITDA
C$ -33.72MC$ -37.40MC$ -22.14MC$ -21.96MC$ -2.01M
Operating Income
C$ -36.99MC$ -36.90MC$ -22.63MC$ -20.87MC$ -2.25M
Other Income/Expenses
C$ 1.73MC$ -2.29MC$ -64.07KC$ -5.46MC$ -1.76M
Pretax Income
C$ -35.27MC$ -39.18MC$ -23.92MC$ -23.37MC$ -4.01M
Net Income
C$ -34.94MC$ -37.39MC$ -23.26MC$ -22.99MC$ -4.00M
Per Share Metrics
Basic EPS
C$ -1.03C$ -1.58C$ -1.21C$ -1.61C$ -0.31
Diluted EPS
C$ -1.03C$ -1.58C$ -1.21C$ -1.61C$ -0.31
Weighted Average Shares Outstanding
33.93M 24.15M 19.29M 14.24M 12.87M
Weighted Average Shares Outstanding (Diluted)
33.93M 24.15M 19.29M 14.24M 12.87M
Currency in CAD

Eupraxia Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis